Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonin autoreceptor subsensitivity and antidepressant activity.

C Moret1, M Briley

  • 1Centre de Recherche Pierre Fabre, Castres, France.

European Journal of Pharmacology
|May 16, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The von Willebrand factor/ADAMTS13 ratio as an indicator of venous thromboembolism risk: results from the RETROVE project.

Journal of thrombosis and thrombolysis·2025
Same author

Under-correction of preoperative varus alignment does not lead to a difference in in-vivo bone loading in 3D-SPECT/CT compared to neutral alignment.

The Knee·2022
Same author

Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders.

Human genomics·2016
Same author

The unique effect of methiothepin on the terminal serotonin autoreceptor in the rat hypothalamus could be an example of inverse agonism.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Effects of scopolamine treatment and lesion of the nucleus basalis upon various cholinergic markers in the rat brain cortex.

Neurochemistry international·2010
Same author

In vivo [(3)H]ketanserin binding: effect of modifying synaptic serotonin levels.

Neurochemistry international·2010

Chronic citalopram treatment down-regulates serotonin autoreceptors, increasing serotonin neurotransmission. Milnacipran did not affect these parameters, suggesting autoreceptor down-regulation isn't universal for all serotonin uptake inhibitors.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Serotonin (5-HT) plays a crucial role in regulating mood and behavior.
  • Antidepressants often target serotonin reuptake, but their precise mechanisms, especially regarding autoreceptor modulation, require further investigation.
  • Serotonergic autoreceptors modulate serotonin release, influencing overall neurotransmission.

Purpose of the Study:

  • To investigate the effects of chronic antidepressant administration on [3H]serotonin release and autoreceptor function in the rat hypothalamus.
  • To compare the impact of a selective serotonin reuptake inhibitor (citalopram) with a dual serotonin-noradrenaline reuptake inhibitor (milnacipran) on serotonergic neurotransmission.

Main Methods:

  • Rats received chronic daily administration of citalopram (10 and 50 mg/kg) or milnacipran (50 mg/kg) for 21 days.

Related Experiment Videos

  • Electrical stimulation was used to elicit [3H]serotonin release from hypothalamic tissue.
  • The modulatory effects of a serotonergic agonist (LSD) on stimulated serotonin release were assessed.

    • Main Results:

    • Chronic citalopram treatment dose-dependently enhanced [3H]serotonin release.
    • Citalopram treatment reduced the inhibitory effect of LSD, indicating reduced autoreceptor function.
    • Milnacipran treatment did not significantly alter any of the studied parameters related to serotonin release or autoreceptor function.

    Conclusions:

    • Chronic citalopram administration leads to down-regulation of the somatodendritic serotonin autoreceptor in the rat hypothalamus.
    • This autoreceptor down-regulation facilitates increased serotonin neurotransmission.
    • The findings suggest that serotonin autoreceptor down-regulation may not be a universal mechanism for all antidepressants that inhibit serotonin reuptake.